These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16754269)

  • 1. Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) - a review.
    Zanchetti A; Elmfeldt D
    Blood Press; 2006; 15(2):71-9. PubMed ID: 16754269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Study on COgnition and Prognosis in the Elderly (SCOPE)--recent analyses.
    Trenkwalder P
    J Hypertens Suppl; 2006 Mar; 24(1):S107-14. PubMed ID: 16601563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE).
    Skoog I; Lithell H; Hansson L; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
    Am J Hypertens; 2005 Aug; 18(8):1052-9. PubMed ID: 16109319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
    Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
    J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE).
    Degl'Innocenti A; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A; Wiklund I
    J Hum Hypertens; 2004 Apr; 18(4):239-45. PubMed ID: 15037872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Study on COgnition and Prognosis in the Elderly (SCOPE) - major CV events and stroke in subgroups of patients.
    Trenkwalder P; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Papademetriou V; Skoog I; Zanchetti A;
    Blood Press; 2005; 14(1):31-7. PubMed ID: 15823945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing cardiovascular morbidity and mortality in the elderly.
    Trenkwalder P
    Blood Press Suppl; 2000; 1():40-3. PubMed ID: 11059636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
    Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
    J Hypertens; 2003 May; 21(5):875-86. PubMed ID: 12714861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SCOPE trial. Study on Cognition and Prognosis in the Elderly.
    Sever P
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):61-2. PubMed ID: 12228843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization.
    Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
    J Hypertens; 2004 Aug; 22(8):1605-12. PubMed ID: 15257185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
    London G; Schmieder R; Calvo C; Asmar R
    Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on COgnition and Prognosis in the Elderly (SCOPE).
    Hansson L; Lithell H; Skoog I; Baro F; Bánki CM; Breteler M; Carbonin PU; Castaigne A; Correia M; Degaute JP; Elmfeldt D; Engedal K; Farsang C; Ferro J; Hachinski V; Hofman A; James OF; Krisin E; Leeman M; de Leeuw PW; Leys D; Lobo A; Nordby G; Olofsson B; Zanchetti A
    Blood Press; 1999; 8(3):177-83. PubMed ID: 10595696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the Elderly.
    Lundkvist J; Ekman M; Kartman B; Carlsson J; Jönsson L; Lithell H
    J Hum Hypertens; 2005 Jul; 19(7):569-76. PubMed ID: 15800664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics.
    Hansson L; Lithell H; Skoog I; Baro F; Bánki CM; Breteler M; Castaigne A; Correia M; Degaute JP; Elmfeldt D; Engedal K; Farsang C; Ferro J; Hachinski V; Hofman A; James OF; Krisin E; Leeman M; de Leeuw PW; Leys D; Lobo A; Nordby G; Olofsson B; Opolski G; Prince M; Reischies FM
    Blood Press; 2000; 9(2-3):146-51. PubMed ID: 10855739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex).
    Ogihara T; Ueshima K; Nakao K; Fukiyama K; Oba K; Yasuno S; Fujimoto A; Sato T; Matsuoka H; Saruta T;
    Hypertens Res; 2011 Dec; 34(12):1295-301. PubMed ID: 21833000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.
    Saxby BK; Harrington F; Wesnes KA; McKeith IG; Ford GA
    Neurology; 2008 May; 70(19 Pt 2):1858-66. PubMed ID: 18458219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial.
    Nakao K; Hirata M; Oba K; Yasuno S; Ueshima K; Fujimoto A; Ogihara T; Saruta T;
    Hypertens Res; 2010 Jun; 33(6):600-6. PubMed ID: 20379187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switch from ABCD pretreatment to A-II-A treatment: a multinational, open, centrally randomized, prospective parallel group comparison.
    Asmar R; Porcellati C; Dusing R
    Drugs Exp Clin Res; 2004; 30(4):153-61. PubMed ID: 15553661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.